Dermatology Clinical Assessment and Treatment Services to be delivered to NHS GM ICB.

NHS Greater Manchester Integrated Care Board (ICB) is in the procurement stage for a contract titled "Dermatology Clinical Assessment and Treatment Services". The contract, which falls under the services industry category specifically focused on dermatology services (CPV: 85121282), is to be delivered in the UKD region. The process utilised a limited procurement method under the Provider Selection Regime (PSR), without prior publication of a call for competition.

The contract covers services from 1st April 2024 to 31st March 2025, with a total value of £1,370,499. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023, with a standstill period allowing for representations to be made until midnight on 23rd April 2025. Key dates to note include the intention to award notice dated 9th April 2025.

This tender presents substantial opportunities for businesses specialising in healthcare services, particularly those with expertise in dermatology. Given the critical role of quality, innovation, and integration in the award criteria, businesses that focus on service sustainability, improving access, reducing health inequalities, and facilitating choice will be well-suited to compete. Specifically, the contract emphasises factors such as quality and innovation (25%), value (20%), integration and service sustainability (30%), access and health equality (15%), and social value (10%).

The successful supplier, identified as DMC Dermatology (formally Durnford Healthcare), indicates the importance of experienced providers in this competitive landscape, creating growth opportunities for businesses with a strong track record in delivering high-quality healthcare services.